FIELD: chemistry.
SUBSTANCE: invention relates to biotechnology, in particular to obtaining a population of central memory T-lymphocytes, and can be used in medicine. A population of cells is obtained, having a central memory T-lymphocyte (Tcm) phenotype and which do not induce anti third party GVHD, wherein at least 50% of the cells have the CD8+, CD62L+, CD45RA-, CD45 RO+ signature.
EFFECT: invention enables to obtain a population of tolerance inducing cells that are capable of homing to lymph nodes after transplantation.
15 cl, 13 dwg, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CENTRAL MEMORY T-CELLS OF AGAINST THIRD PARTY, METHODS FOR THEIR PRODUCTION AND THEIR APPLICATION IN TRANSPLANTATION AND DISEASES TREATMENT | 2012 |
|
RU2636503C2 |
| VETO-CELLS OBTAINED FROM MEMORY T-CELLS | 2017 |
|
RU2779844C2 |
| COMBINATION THERAPY FOR STABLE AND LONG TERM ENGRAFTMENT USING SPECIFIC PROTOCOLS FOR T/B-CELL DEPLETION | 2012 |
|
RU2648354C2 |
| COMBINATION THERAPY FOR STABLE AND LONG-TERM TRANSPLANT ENGRAFTMENT | 2012 |
|
RU2657758C2 |
| METHOD AND COMPOSITIONS FOR CELLULAR IMMUNOTHERAPY | 2012 |
|
RU2688185C2 |
| INDUCTION OF IMMUNE TOLERANCE USING METHOTREXATE | 2012 |
|
RU2674036C2 |
| DEVICES AND METHODS FOR SELECTION OF CELLS RESISTANT TO APOPTOTIC SIGNALS AND THEIR APPLICATIONS | 2013 |
|
RU2630301C2 |
| METHODS FOR INDUCING T-CELLULAR TOLERANCE FOR TISSUE OR ORGAN TRANSPLA - NT | 1995 |
|
RU2169009C2 |
| METHODS OF INCREASING EFFICIENCY OF DEPLETION OF TCRαβ+ CELLS | 2020 |
|
RU2829624C2 |
| METHOD OF TREATING IMMUNE DYSFUNCTION, SUCH AS GRAFT-VERSUS-HOST OR HOST-VERSUS-GRAFT DISEASE | 2006 |
|
RU2497530C2 |
